Related Experiment Video
Updated: Feb 11, 2026

Site-Directed φC31-Mediated Integration and Cassette Exchange in Anopheles Vectors of Malaria
Published on: February 2, 2021
Heightened Nontesting Risk Mitigation Blood Donor Screening with Retrospective Transcription-Mediated Amplification
David J Sullivan1, Marion C Lanteri2,3, Vanessa Bres4
1W. Harry Feinstone Department of Molecular Microbiology and Immunology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.
Transfusion-transmitted malaria is rare in the U.S. Following a 2023 Florida outbreak, enhanced screening and pathogen reduction strategies were implemented, finding no malaria in blood donations.
Area of Science:
- Infectious Diseases
- Public Health
- Blood Transfusion Safety
Background:
- Transfusion-transmitted malaria (TTM) poses a minimal but persistent risk in the U.S., with recent cases linked to individuals outside deferral periods.
- Autochthonous malaria outbreaks, such as the 2023 Plasmodium vivax outbreak in Florida, highlight potential transmission routes beyond travel history.
- The absence of an approved blood donor screening test for malaria necessitates proactive risk mitigation strategies.
Purpose of the Study:
- To evaluate the effectiveness of enhanced blood donor screening and pathogen reduction measures implemented during a local malaria outbreak.
- To assess the prevalence of malaria in blood donors from affected and surrounding areas using nucleic acid testing (NAT).
- To investigate the risk of transfusion-transmitted malaria in the context of an autochthonous malaria outbreak.
Main Methods:
- Retrospective analysis of blood donor samples using transcription-mediated amplification (TMA) NAT.
- Targeted nucleic acid testing on samples from specific zip codes in Sarasota and Miami, Florida.
- Implementation of non-testing donor risk mitigation strategies including enhanced screening and pathogen reduction by a local blood center.
Main Results:
- All tested donor samples (n=436) from Sarasota and Miami zip codes were nonreactive for malaria via nucleic acid testing.
- No transfusion-transmitted malaria cases were reported locally during the study period.
- Mosquito control, increased syndromic surveillance, and blood center interventions were implemented concurrently.
Conclusions:
- Enhanced blood donor screening and pathogen reduction strategies appear effective in mitigating TTM risk during local malaria outbreaks.
- Nucleic acid testing did not detect malaria in the studied donor population, supporting the safety of the blood supply.
- A multi-faceted approach involving public health, vector control, and blood banking is crucial for managing TTM risks.
Related Concept Videos
Transcription Factors
Eukaryotic Transcription Activators
The binding domains are capable of recognizing and interacting with regulatory sequences on the DNA. These...
Transcription
Transcription is the process of synthesizing RNA from a DNA sequence by RNA polymerase. It is the first step in producing a protein from a gene sequence. Additionally, many other proteins and regulatory sequences are involved in the proper synthesis of messenger RNA (mRNA). Regulation of transcription is responsible for the differentiation of all the different types of cells and often for the proper cellular response to environmental signals.
Transcription Can Produce Different Kinds...
Prokaryotic Transcriptional Activators and Repressors
Transcription of prokaryotic...
Relative Risk
Eukaryotic Transcription Inhibitors
Eukaryotic transcription inhibitors usually contain two distinct domains, a...

